Innovation

Enterotoxin-Deficient Bacillus Strains for Use as Biocontrol Agents

Wisconsin Alumni Research Foundation (University of Wisconsin)
posted on 09/29/2011

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing Bacillus strains that have been modified so they do not produce enterotoxin products that are associated with human toxicity.

Suggested Uses

  • Use of B. thuringiensis as an agricultural biocontrol agent

Advantages

  • Removes the enterotoxin products associated with human toxicity, improving the B. thuringiensis strain for use as a biocontrol agent
  • Performs as well as the wild-type strain
  • Does not include any added DNA and therefore is not considered genetically engineered by the Environmental Protection Agency

Innovation Details
 

Detailed Description

Bacillus thuringiensis, which produces several proteins that are specifically toxic to plant pests, is used widely as an agricultural biocontrol agent. However, concern about the widespread use of B. thuringiensis on food crops is growing because B. thuringiensis is closely related to B. cereus, a known food contaminant that can cause diarrhea in humans due to the expression of enterotoxin genes. Most commercial B. thuringiensis strains also contain and express enterotoxin genes.

The major difference between B. thuringiensis and B. cereus appears to be the presence of plasmids in B. thuringiensis that encode an insecticidal crystal toxin. Therefore, constructing enterotoxin-deficient mutants of existing commercial B. thuringiensis strains should enhance the safety of B. thuringiensis for food crops while maintaining its effectiveness as a biocontrol agent.

UW–Madison researchers previously developed methods for making Bacillus strains in which a component of the HBL enterotoxin is disrupted. However, while these strains demonstrated reduced enterotoxin activity, they continued to exhibit low levels of enterotoxin.

UW–Madison researchers have now created improved mutants of B. thuringiensis for use as bioinsecticides on food crops. In the modified strains, four distinct operons, each comprising three genes that encode unique enterotoxins that have been implicated in food poisoning, have been replaced with copies containing deletions, rendering the enterotoxins non-functional. The quadruple enterotoxin-deficient strains do not produce the enterotoxin products that are associated with human toxicity, yet perform as well as the wild-type B. thuringiensis strain.

File Number: P08212US02 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Emily Bauer at Wisconsin Alumni Research Foundation (University of Wisconsin) for more information.

Request more info via email request more info
People

Case Manager:

Emily Bauer Emily Bauer

Innovations (117)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Alfred R Berkeley, Chairman, Pipeline Financial Group, Inc., Former President and Vice Chairman, Nasdaq Stock Market, Inc.

"Our economy is inextricably intertwined with university innovations. Unfortunately, our country’s short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs..."  read more...